BE748897A - Procede pour la realisation de formes pharmaceutiques deshydratees ou desolvatees par lyophilisation et formes pharmaceutiques ainsi obtenus - Google Patents

Procede pour la realisation de formes pharmaceutiques deshydratees ou desolvatees par lyophilisation et formes pharmaceutiques ainsi obtenus

Info

Publication number
BE748897A
BE748897A BE748897DA BE748897A BE 748897 A BE748897 A BE 748897A BE 748897D A BE748897D A BE 748897DA BE 748897 A BE748897 A BE 748897A
Authority
BE
Belgium
Prior art keywords
pharmaceutical forms
desolvated
lyophilization
realization
dehydrated
Prior art date
Application number
Other languages
English (en)
Inventor
P Blonde Le
Original Assignee
Orsymonde
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR696911589A external-priority patent/FR2036890B1/fr
Priority claimed from FR7010548A external-priority patent/FR2081586A2/fr
Application filed by Orsymonde filed Critical Orsymonde
Publication of BE748897A publication Critical patent/BE748897A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
BE748897D 1969-04-15 1970-04-14 Procede pour la realisation de formes pharmaceutiques deshydratees ou desolvatees par lyophilisation et formes pharmaceutiques ainsi obtenus BE748897A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR696911589A FR2036890B1 (fr) 1969-04-15 1969-04-15
FR7010548A FR2081586A2 (en) 1970-01-24 1970-01-24 Dehydrated pharmaceutical comps by - lyophilisation

Publications (1)

Publication Number Publication Date
BE748897A true BE748897A (fr) 1970-09-16

Family

ID=26214959

Family Applications (1)

Application Number Title Priority Date Filing Date
BE748897D BE748897A (fr) 1969-04-15 1970-04-14 Procede pour la realisation de formes pharmaceutiques deshydratees ou desolvatees par lyophilisation et formes pharmaceutiques ainsi obtenus

Country Status (4)

Country Link
US (1) US3778510A (fr)
BE (1) BE748897A (fr)
DE (1) DE2017373A1 (fr)
GB (1) GB1310824A (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3928566A (en) * 1970-08-14 1975-12-23 Du Pont Lyophilized biological products
GB1548022A (en) * 1976-10-06 1979-07-04 Wyeth John & Brother Ltd Pharmaceutial dosage forms
IE45770B1 (en) * 1976-10-06 1982-11-17 Wyeth John & Brother Ltd Pharmaceutical dosage forms
CA1097233A (fr) 1977-07-20 1981-03-10 George K. E. Gregory Emballages
FR2539626B2 (fr) * 1983-01-25 1985-06-21 Lafon Labor Nouveau procede de preparation de formes galeniques utiles notamment en therapeutique, dietetique, cosmetique et diagnostic, et formes obtenues selon ce procede
FR2561916B1 (fr) * 1984-03-30 1987-12-11 Lafon Labor Forme galenique pour administration orale et son procede de preparation par lyophilisation d'une emission huile dans eau
DE3628468A1 (de) * 1986-08-21 1988-03-03 Thomae Gmbh Dr K Neue applikationsformen fuer (alpha)-interferone
DE3801179A1 (de) * 1988-01-18 1989-07-27 Hoechst Ag Stabilisierung von cephalosporinderivaten durch trocknung mit einem stabilisator sowie stabile zubereitungsformen mit cephalosporinderivaten
DE3801178A1 (de) * 1988-01-18 1989-07-27 Hoechst Ag Stabilisierte trockenzubereitung zytostatisch wirksamer anthracyclin-antibiotika und verfahren zu ihrer herstellung
FR2634376B1 (fr) * 1988-07-21 1992-04-17 Farmalyoc Nouvelle forme unitaire, solide et poreuse comprenant des microparticules et/ou des nanoparticules, ainsi que sa preparation
US5055296A (en) * 1988-08-04 1991-10-08 Wagle Sudhakar S Method of treating chronic fatigue syndrome
US5284664A (en) * 1988-08-04 1994-02-08 Kremers-Urban Company Method of treating the symptoms of Alzheimer's disease
US5316775A (en) * 1988-08-04 1994-05-31 Kremers-Urban Company Method of treating hepatitis B infection
US5334395A (en) * 1988-08-04 1994-08-02 Kremers-Urban Company Method of treating an epstein-barr viral infection
US5206025A (en) * 1989-05-24 1993-04-27 Rhone-Poulenc Sante Porous pharmaceutical form and its preparation
US5215756A (en) * 1989-12-22 1993-06-01 Gole Dilip J Preparation of pharmaceutical and other matrix systems by solid-state dissolution
GR910100193A (el) * 1991-05-03 1993-03-31 Mediventures Inc Παρασκευη φαρμακευτικων και αλλων περιβληματων με διαλυση σε στερεα κατασταση.
IL101007A (en) * 1992-02-18 1997-08-14 Pharmos Ltd Dry stable compositions prepared by lyophilization
IL105553A (en) 1992-05-06 1998-01-04 Janssen Pharmaceutica Inc Solid dosage forms consisting of a porous network of matrix that releases a substance that dissipates rapidly in water
EP1110550B2 (fr) * 1999-12-22 2007-04-04 DSM IP Assets B.V. Composition contenant de l'acide ascorbique comme agent principal et de la pectine
JP4339685B2 (ja) * 2001-09-03 2009-10-07 ディーエスエム アイピー アセッツ ビー．ブイ． ペクチン及びアスコルビン酸を含む組成物
DE10254334A1 (de) * 2002-11-21 2004-06-03 Beiersdorf Ag Kosmetikkonzentrat
EP2243472B1 (fr) 2009-04-22 2017-04-05 MedSkin Solutions Dr. Suwelack AG Composition de matière active séchée par congélation

Also Published As

Publication number Publication date
DE2017373A1 (de) 1971-04-22
GB1310824A (en) 1973-03-21
US3778510A (en) 1973-12-11

Similar Documents

Publication Publication Date Title
BE748897A (fr) Procede pour la realisation de formes pharmaceutiques deshydratees ou desolvatees par lyophilisation et formes pharmaceutiques ainsi obtenus
FR2286511A2 (fr) Joint pour connexion et son procede de realisation
BE807706A (fr) Procede pour la preparation de cycloalcanones et/ou cycloalcanols
BE776518A (fr) Procede pour la preparation de polylactones
BE776784A (fr) Procede pour la preparation de derives hydroperoxydes de polymeres
BE784779A (fr) Procede de preparation de l'acrylamide et du methacrylamide
BE744641A (fr) Procede pour la preparation de 2-mercapto-benzthiazol
BE812811A (fr) Nouveau procede de preparation des formes pharmaceutiques deshydratees ou desolvatees par lyophilisation
BE776530A (fr) Procede pour la preparation de 5-vinylnorbornene-2
BE777265A (fr) Procede de preparation de 1,5-dimethyl-naphtalene et/ou de 1-6-dimethyl-naphtalene et composition catalytique utilisee pour ledit procede
BE773013A (fr) Procede pour la preparation de peptides
BE756350A (fr) Procede pour la preparation de 5-methylene-2, 4-oxazolidine-diones et composes ainsi obtenus
BE806277A (fr) Procede pour la preparation de cycloalcanones et de cycloalcanols
BE745938A (fr) Procede pour la preparation de cycloalcenones
BE754420A (fr) Procede pour la preparation de 4-ureidohexahydropyrimidinone -(2)
BE762598A (fr) Procede pour la preparation de 2-ethylhexanal-(1)
BE764203A (fr) Procede pour la preparation d'indenophtalazines
BE764840A (fr) Procede pour la preparation de citronellal
BE772818A (fr) Procede pour la preparation de derives de
BE754504A (fr) Procede pour la preparation de benzothiazylsulfenamides
BE745469A (fr) Procede pour la preparation de gamma-cyanobutyraldimines
BE763637A (fr) Procede pour la preparation de thiourees symetriques 1,3- disubstitueesaliphatiques et cycloaliphatiques
BE766147A (fr) Procede pour la preparation de steroides
BE773443A (fr) Procede pour la preparation de 1-chloro-3-methyl-2-
BE744915A (fr) Procede pour la preparation de 4-carboxy-2-piperidone et de sesesters

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: ORSYMONDE

Effective date: 19900414